Every material Form 8-K MetLife has filed with the SEC since June 24, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
MetLife reported its third-quarter 2026 financial results, highlighted by net income of $2.4 billion, or $3.67 per share, driven by net derivative gains and higher adjusted earnings. Adjusted earnings increased 12% to $1.8 billion, supported by higher variable investment income, broad-based volume growth, and favorable underwriting. The company returned approximately $1 billion to shareholders through share repurchases and common stock dividends during the quarter.
Net income increased 187% to $2.4 billion, or $3.67 per share, for the third quarter of 2026.
Adjusted earnings rose 12% to $1.8 billion, or $2.78 per share.
Premiums, fees and other revenues increased 12% to $14.1 billion.
Total assets under management for MetLife Investment Management reached $723.4 billion.
MetLife reported results for the quarter ended June 30, 2026, with adjusted earnings up 15% to $1.6 billion and adjusted earnings per share up 20% to $2.43. Net income rose 1% to $705 million, or $1.09 per share, and premiums, fees and other revenues grew 7% to $13.7 billion. The board also approved a new $3.0 billion authorization to repurchase common stock.
Adjusted earnings rose 15% to $1.6 billion ($1,573 million); adjusted earnings per share rose 20% to $2.43.
Net income rose 1% to $705 million, or $1.09 per share, up 6% on a per-share basis.
Premiums, fees and other revenues rose 7% to $13.7 billion; net investment income rose 18% to $6.7 billion.
On August 5, 2026, the board approved a new $3.0 billion common stock repurchase authorization.
MetLife reported first-quarter 2026 results that improved on the prior-year quarter, with net income up 30% to $1.1 billion and adjusted earnings up 18% to $1.6 billion. Adjusted premiums, fees and other revenues excluding pension risk transfers rose 10% to $13.3 billion, and the company returned over $1.1 billion to shareholders through buybacks and dividends.
Net income was $1.1 billion, or $1.74 per share, up 30% (36% per share); adjusted earnings per share rose 23% to $2.42.
Premiums, fees and other revenues rose 5% to $14.3 billion; excluding pension risk transfers, they rose 10% to $13.3 billion.
Variable investment income rose 58% to $518 million, driven by higher private equity returns.
Holding company cash and liquid assets totaled $3.9 billion at March 31, 2026, at the top of the target range.
MetLife's Board increased its size from eleven to thirteen directors and elected Daniel S. Glaser and Michelle R. Seitz, both determined to be independent. The new directors receive the standard non-management director pay, which is a $355,000 annual retainer split between shares and cash.
Board expanded from eleven to thirteen directors on February 24, 2026, effective immediately
Glaser joins the Audit, Compensation, and Finance and Risk committees; Seitz joins the Compensation, Governance and Corporate Responsibility, and Investment committees
Standard non-management retainer is $355,000 per year: $205,000 in company stock and $150,000 in cash, with partial-year service pro-rated
MetLife reported fourth-quarter 2025 net income of $778 million, or $1.17 per share, down 37% from a year earlier, mainly due to net derivative and investment losses. Adjusted earnings per share excluding total notable items rose 24% to $2.58, and the company maintained its near-term 2026 targets for adjusted return on equity and double-digit adjusted EPS growth. The mixed picture matters to shareholders because reported profit fell sharply while the company's adjusted measures and revenue grew.
Q4 net income was $778 million ($1.17 per share), versus $1,239 million ($1.78 per share) a year earlier; net derivative losses were $646 million.
Q4 adjusted EPS excluding total notable items rose 24% to $2.58; full-year figure was $8.89, up 10%.
Q4 premiums, fees and other revenues rose 29% to $18.7 billion; adjusted PFOs excluding pension risk transfers rose 8% to $12.8 billion.
2026 outlook maintains adjusted ROE target of 15%-17% and expects the direct expense ratio to be 12.1% for 2026.
MetLife reported third-quarter 2025 net income of $818 million, or $1.22 per share, down 36% from a year earlier, mainly due to higher net derivative losses and net investment losses. Adjusted earnings rose 15% to $1.6 billion, and adjusted earnings per share rose 22% to $2.37, driven by higher variable investment income and volume growth.
Net income was $818 million ($1.22 per share), down 36% from $1,275 million in the third quarter of 2024; net derivative losses were $929 million.
Adjusted earnings were $1,584 million, up 15%; adjusted earnings per share were $2.37, up 22%.
Premiums, fees and other revenues were $12.5 billion, flat compared with the prior-year quarter.
MetLife returned approximately $875 million to shareholders through share repurchases and common stock dividends, and held $4.9 billion in holding company cash and liquid assets at quarter end.
MetLife reported second-quarter 2025 net income of $698 million, down 23% from a year earlier, and adjusted earnings of $1.4 billion, down 16%. The company said higher net derivative losses and lower adjusted earnings drove the net income decline, while premiums, fees and other revenues fell 6% to $12.7 billion. Shareholders also received approximately $900 million through share repurchases and dividends during the quarter.
Net income was $698 million, down 23%, or $1.03 per share, down 20%.
Adjusted earnings were $1.4 billion ($1,362 million), down 16%, or $2.02 per share, down 11%.
Adjusted premiums, fees and other revenues excluding pension risk transfers rose 5% to $12.4 billion.
Book value per share rose 7% to $35.79; the company returned approximately $900 million to shareholders.
MetLife announced that Adrienne O'Neill, previously Chief Financial Officer for Asia at Manulife Financial, will join as Executive Vice President and Chief Accounting Officer effective September 2, 2025. She replaces interim Chief Accounting Officer Toby Srihiran Brown, who returns to his role as Executive Vice President and Global Head of Reinsurance. The change fills a key finance leadership role responsible for corporate accounting and reporting.
O'Neill's annual base salary is $525,000, with eligibility for a discretionary incentive award.
Sign-on stock-based long-term incentive awards have an aggregate grant date value of $1,950,000, plus certain sign-on cash payments.
O'Neill will report to CFO John McCallion, and her start date is September 2, 2025.
Brown served as interim Chief Accounting Officer since March 2025.
MetLife reported first-quarter 2025 net income up 10% to $879 million, or $1.28 per share, and premiums, fees and other revenues up 14% to $13.6 billion. Adjusted earnings rose 1% to $1.3 billion, while net investment income fell 10% to $4.9 billion. The company also approved a new $3.0 billion share repurchase authorization and agreed in April to reinsure about $10 billion of U.S. retail variable annuity and rider reserves.
Adjusted earnings rose 1% to $1.3 billion; adjusted earnings per share rose 7% to $1.96.
Premiums, fees and other revenues rose 14% to $13.6 billion for the quarter ended March 31, 2025.
Board approved a new $3.0 billion share repurchase authorization; MetLife returned $1.8 billion to shareholders via buybacks and dividends in the quarter.
In April, MetLife agreed with a subsidiary of Talcott Financial Group to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves.
MetLife director David L. Herzog notified the board on March 27, 2025 that he will resign effective May 1, 2025, and will not stand for re-election at the 2025 annual shareholder meeting. The filing says the resignation was not due to any disagreement with the company on its operations, policies or practices.
Resignation notice given to the board on March 27, 2025
Resignation effective May 1, 2025; Herzog will not seek re-election at the 2025 annual meeting
Filing states no disagreement with the company on operations, policies or practices
MetLife appointed Toby Srihiran Brown, its Executive Vice President and Global Head of Reinsurance, as interim Chief Accounting Officer effective March 15, 2025, while it searches for a permanent replacement for Tamara Schock, who previously gave notice of her resignation. The board also expanded itself to fourteen directors and added Christian Mumenthaler, effective May 1, 2025.
Toby Srihiran Brown, age 51, named interim Chief Accounting Officer effective March 15, 2025
Tamara L. Schock, who gave notice of resignation on January 7, 2025, remains principal accounting officer until Brown's appointment takes effect
Board increased from thirteen to fourteen directors; Christian Mumenthaler elected, joining the Finance and Risk and Investment Committees
Non-management directors receive a $325,000 annual retainer, $175,000 in stock and $150,000 in cash
MetLife reported fourth quarter 2024 net income of $1.2 billion, or $1.78 per share, up from $574 million, or $0.77 per share, a year earlier. Adjusted earnings per share rose 14% to $2.09, and full year adjusted earnings per share rose 12% to $8.15. The company also raised its adjusted return on equity target to 15% to 17% from 13% to 15%, set a new target of double-digit adjusted earnings per share growth, and lowered its direct expense ratio target.
Q4 2024 net income was $1.2 billion, or $1.78 per share, versus $574 million, or $0.77 per share, in Q4 2023.
Q4 2024 adjusted earnings were $1.5 billion, or $2.09 per share, versus $1.83 per share a year earlier; full year adjusted earnings per share were $8.15, up 12%.
Q4 2024 premiums, fees and other revenues were $14.5 billion, up 6% from the prior-year quarter.
Adjusted ROE target raised to 15% to 17%; direct expense ratio target lowered from 12.3% to 12.1% over the near term and 11.3% over the New Frontier period.
MetLife said its Executive Vice President and Chief Accounting Officer, Tamara L. Schock, will resign to pursue another opportunity, with her last day expected on or about March 14, 2025. The company said her decision was due to personal reasons and not a disagreement over financial statements, internal controls, operations, policies or practices.
Tamara L. Schock informed MetLife of her resignation on January 7, 2025
Her last day of employment is expected on or about March 14, 2025
The filing states the departure was for personal reasons, not a disagreement with the company
The 8-K filing was dated January 10, 2025 and signed by Timothy J. Ring, Senior Vice President and Secretary
MetLife reported third quarter 2024 net income of $1.3 billion, or $1.81 per share, up from $422 million a year earlier, driven mainly by net derivative gains. Adjusted earnings fell 8 percent to $1.4 billion, or $1.95 per share, and adjusted premiums, fees and other revenues declined 5 percent, so shareholders see a mixed picture of reported profit gains alongside weaker core measures.
Net income was $1.3 billion ($1.81 per share) versus $422 million ($0.56 per share) in Q3 2023, mainly from net derivative gains of $767 million.
Adjusted earnings were $1.4 billion ($1.95 per share), down 8 percent in dollars and 1 percent per share from $1.97 a year earlier.
Adjusted premiums, fees and other revenues fell 5 percent to $12.5 billion, while adjusted net investment income rose 2 percent to $5.1 billion.
Book value per share rose 33 percent to $39.02; holding company cash and liquid assets were $4.5 billion at September 30, 2024.
MetLife reported second quarter 2024 net income of $912 million, or $1.28 per share, up from $370 million, or $0.48 per share, a year earlier. Adjusted earnings rose 9 percent to $1.6 billion, or $2.28 per share, while premiums, fees and other revenues were essentially flat at $13.5 billion. For shareholders, the higher earnings are offset in part by book value per share, which fell 5 percent to $33.30.
Net income of $912 million, or $1.28 per share, versus $370 million, or $0.48 per share, in Q2 2023
Adjusted earnings of $1.6 billion, or $2.28 per share, up 18 percent per share from $1.94
Book value per share of $33.30, down 5 percent from $34.92 at June 30, 2023
Group Benefits adjusted earnings rose 43 percent to $533 million
At its June 18, 2024 annual meeting, MetLife shareholders elected 13 directors, ratified Deloitte & Touche LLP as auditor for 2024, and approved the MetLife, Inc. 2025 Stock and Incentive Compensation Plan, effective January 1, 2025. Shareholders did not approve a shareholder proposal requesting a third-party racial equity audit, and they approved the named executive officer compensation on an advisory basis.
Stock plan approved with 582,251,541 votes for and 21,677,385 against; the plan covers equity grants to employees, executive officers and non-management directors.
Shareholder racial equity audit proposal failed, with 99,437,619 votes for and 501,548,093 against.
Deloitte & Touche LLP ratified as independent auditor for 2024 with 615,941,976 votes for and 32,282,137 against.
The Board also approved the MetLife Annual Variable Incentive Plan on June 18, 2024, for performance periods beginning on or after January 1, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every MetLife filing is on SEC EDGAR ↗. 8-K briefs of other companies →